EARNED WEALTH ADVISORS, LLC

Position in LLY — ELI LILLY & Co

CIK 1905663 WALNUT CREEK, CA

Position in LLY

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,775,481

-$565,123 QoQ

Shares Held

2,314

-36.3% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.02%

of 13F equity value

Holder Rank

#2,197

of 4,605 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

EARNED WEALTH ADVISORS, LLC holds $8,347,145 across 10 Drug Manufacturers - General names. LLY ranks #1 (33.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,314	$2,775,481
2	JNJ	Johnson & Johnson	6,284	$1,595,947
3	ABBV	AbbVie Inc.	5,103	$1,284,118
4	GILD	Gilead Sciences, Inc.	7,324	$925,314
5	MRK	Merck & Co., Inc.	3,294	$423,279
6	PFE	Pfizer Inc	15,837	$381,354
7	BMY	Bristol Myers Squibb Co	4,515	$260,154
8	AZN	Astrazeneca PLC	1,288	$244,230

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,775,481	2,314	-36.3%	Shares	Sole	2026-08-14
2026-03-31	$3,340,604	3,632	+13.6%	Shares	Sole	2026-05-07
2025-12-31	$3,436,826	3,198	+16.5%	Shares	Sole	2026-01-27
2025-09-30	$2,095,198	2,746	+21.9%	Shares	Sole	2025-10-22
2025-06-30	$1,755,501	2,252	-16.3%	Shares	Sole	2025-08-04
2025-03-31	$2,220,871	2,689	+356.5%	Shares	Sole	2025-05-09
2024-12-31	$454,708	589	-22.5%	Shares	Sole	2025-01-31
2024-09-30	$673,314	760	+65.2%	Shares	Sole	2024-11-01
2024-06-30	$416,474	460	+8.5%	Shares	Sole	2024-08-02
2024-03-31	$329,855	424	+13.7%	Shares	Sole	2024-04-26
2023-12-31	$217,429	373	—	Shares	Sole	2024-02-06
No filing history on record for this holder in this stock.